Karen Flynn Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen Flynn. Karen Flynn is a President, America's Region in WEST PHARMACEUTICAL SERVICES INC ($WST) and a President, Pharma Pckg Systems in WEST PHARMACEUTICAL SERVICES INC ($WST) and a Sr VP & Chief Commercial Offic in WEST PHARMACEUTICAL SERVICES INC ($WST) and a Director in Recro Pharma, Inc. ($REPH) and a Pres. Biologics & CCO in Catalent, Inc. ($CTLT).
Address: 101 GORDON DRIVE LIONVILLE 19341 PA
Companies in which Karen Flynn is an Insider
Catalent, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen Flynn: Pres. Biologics & CCO
Holdings: 35,644 shares
Current Value: $1,010,864
Latest Transaction: Jan 11 2021
$CTLT Market Capitalization: $3.54B
$CTLT Previous Close: $28.36
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Recro Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen Flynn: Director
Holdings: 39,283 shares
Current Value: $316,228
Latest Transaction: Dec 16 2019
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
WEST PHARMACEUTICAL SERVICES INC
Industry: FABRICATED RUBBER PRODUCTS, NEC [3060]
Position of Karen Flynn: Sr VP & Chief Commercial Offic, President, Pharma Pckg Systems, President, America's Region
Holdings: 23,692 shares
Current Value: $2,029,457
Latest Transaction: Feb 21 2019
$WST Market Capitalization: $6.29B
$WST Previous Close: $85.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Karen Flynn
Sentiment: All, CTLT, REPH, WST
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 11 2021 | CTLT | Catalent, Inc. | Flynn Karen | Pres. Biologics & C ... | Sell | S | 112.50 | 1,100 | 123,750 | 34,544 | 35.6 K to 34.5 K (-3.09 %) |
| Jan 11 2021 | CTLT | Catalent, Inc. | Flynn Karen | Pres. Biologics & C ... | Sell | S | 112.14 | 1,378 | 154,529 | 35,644 | 37 K to 35.6 K (-3.72 %) |
| Jan 05 2021 | CTLT | Catalent, Inc. | Flynn Karen | Pres. Biologics & C ... | Sell | S | 104.42 | 99 | 10,338 | 37,022 | 37.1 K to 37 K (-0.27 %) |
| Aug 03 2020 | CTLT | Catalent, Inc. | Flynn Karen | Pres. Biologics & C ... | Option Exercise | A | 88.10 | 8,005 | 705,241 | 8,005 | |
| Aug 03 2020 | CTLT | Catalent, Inc. | Flynn Karen | Pres. Biologics & C ... | Grant | A | 0.00 | 1,476 | 0 | 37,121 | 35.6 K to 37.1 K (+4.14 %) |
| Apr 13 2020 | CTLT | Catalent, Inc. | Flynn Karen | Pres. Biologics & C ... | Grant | A | 56.46 | 359 | 20,269 | 35,645 | 35.3 K to 35.6 K (+1.02 %) |
| Jan 09 2020 | CTLT | Catalent, Inc. | Flynn Karen | Pres. Biologics & C ... | Grant | A | 0.00 | 35,286 | 0 | 35,286 | 0 to 35.3 K |